Evidence map›Paper›PMID 28855536›Full record

ArticleScientific reports2017

Transforming Growth Factor Beta is regulated by a Glucocorticoid-Dependent Mechanism in Denervation Mouse Bone.

Ye Li, Ligang Jie, Austin Y Tian, Shenrong Zhong, Mason Y Tian, Yixiu Zhong, Yining Wang, Hongwei Li, Jinlong Li, Xiaoyan Sun and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Bidirectional Interaction Between the Brain and Bone in Traumatic Brain Injury.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Ye LiSchool of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, China.
Ligang JieDepartment of Chinese Medicine, Guangzhou General Hospital of Guangzhou Command, PLA, Guangzhou, China.
Austin Y TianDepartment of Neurology, University of Chicago, Chicago, IL, USA.
Shenrong ZhongSchool of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, China.
Mason Y TianCollege of Dentistry, University of New York, New York, NY, USA.
Yixiu ZhongSchool of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, China.
Yining WangSchool of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, China.
Hongwei LiSchool of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, China.
Jinlong LiSchool of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, China. lijinlong@smu.edu.cn.
Xiaoyan SunDepartment of Neurology, University of Chicago, Chicago, IL, USA. sunxn263@hotmail.com.
Hongyan DuSchool of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, China. dhy48321@smu.edu.cn.
Southern Medical University · CNUniversity of Chicago · USGeneral Hospital of Guangzhou Military Command · CNNew York University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bone growth and remodeling is inhibited by denervation in adults and children, resulting in alterations of linear growth and bone mass and increased risk for osteoporosis and pathologic fractures. Transforming growth factor beta (TGF-β) isoforms are a key group of growth factors that enhance bone formation. To explore the relation between denervation-induced reduction of bone formation and TGF-β gene expression, we measured mRNA levels of TGF-β in denervation mouse bone and found decreased mRNA levels of TGF-β1, TGF-β2 and TGF-β3. These changes were accompanied by diminishing weight loss, bone mineral density (BMD), trabecular thickness, trabecular separation and trabecular number of femur and lumbar, serum osteocalcin, total calcium, intact parathyroid hormone, and increased serum C telopeptide. Recombinant human TGF-β1 (rhTGF-β1) prevented denervation-induced reduction of BMD further supporting our hypothesis that denervation-induced reduction of bone formation is a result of inhibition of TGF-β gene expression. In addition, antiprogestins RU 38486 blunted the denervation-induced decrease in mRNA levels of TGF-β group, while dexamethasone (DEX) decreased TGF-β group mRNA levels in normal mice. Furthermore, the denervated-mice exhibited a threefold increase in plasma corticosterone. These results suggest that denervation-induced reduction of bone formation may be regulated by glucocorticoids via inhibition of TGF-β gene expression at least in part.

Indexed as

Down-RegulationAnimalsBone and BonesBone DensityCalciumDenervationDexamethasoneGlucocorticoidsMaleMiceOsteocalcinOsteogenesisParathyroid HormoneTransforming Growth Factor betaCalciumDexamethasoneGlucocorticoidsOsteocalcinParathyroid HormoneTransforming Growth Factor beta

Identifiers

PMID28855536
PMCPMC5577242
OpenAlexW2749357213

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.